Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

1,400

Participants

Timeline

Start Date

June 30, 1996

Study Completion Date

October 31, 2010

Conditions
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Interventions
DRUG

chemotherapy

Trial Locations (21)

8

Coombe Women's Hospital, Dublin

St. James' Hospital, Dublin

1000

Institut Jules Bordet, Brussels

1090

Academisch Ziekenhuis der Vrije Universiteit Brussel, Brussels

7925

Groote Schuur Hospital, Cape Town

14076

Centre Regional Francois Baclesse, Caen

25124

Spedali Civili di Brescia, Brescia

28040

Hospital Universitario San Carlos, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

A-1100

Kaiser Franz Josef Hospital, Vienna

B-8500

Cazk Groeninghe - Campus Maria's Voorzienigheid, Kortrijk

1105 AZ

Academisch Medisch Centrum at University of Amsterdam, Amsterdam

2300 RC

Leiden University Medical Center, Leiden

NL-6500 HB

Nijmegen Cancer Center at Radboud University Medical Center, Nijmegen

3008 AE

Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam

2545 CH

Leyenburg Ziekenhuis, The Hague

3508 GA

University Medical Center Utrecht, Utrecht

8000 GK

Isala Klinieken - locatie Sophia, Zwolle

3001-301

Hospitais da Universidade de Coimbra (HUC), Coimbra

08017

Institut d'Oncologia Corachan, Barcelona

HA6 2RN

Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood

Sponsors
All Listed Sponsors
collaborator

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

lead

Medical Research Council

OTHER_GOV